approval from the SEC Office which is in breach of the Securities and Exchange Act B.E. 2535. SEC Act S.33 Settlement Committee Meeting No. 3/2025 Settlement Committee Order No. 40/2025 Dated 25/04/2025
) without the approval from the SEC Office which is in breach of the Securities and Exchange Act B.E. 2535 SEC Act S.33 Settlement Committee Meeting No. 5/2025 Settlement Committee Order No. 90/2025 Dated
Limited’s shares offering in the form of general or to the public without approval from the SEC office. SEC Act S.300 in conjunction with 34 Settlement Committee Meeting No. 7/2025 Settlement Committee
VILLA MEDICA (PHUKET) CO.,LTD Between JUNE 2017 to December 2017, VILLA MEDICA (PHUKET) CO.,LTD offer to sell newly issued securities in the category of Debentures without approval from the SEC
Limited’s shares offering in the form of general or to the public without approval from the SEC office. SEC Act S.300 in conjunction with 34 Criminal Complaint Filed with an Inquiry Official Dated 15/10
Board of Directors has unanimously resolved approve for the Company to participate the vote of approval in the Extraordinary General Meeting of Shareholders No. 1/2019, held on 8 March 2019, in order to
the Annual General Meeting of Shareholders for consideration and approval of the appointment of Mr. Vichai Ruchitanont, Registration No. 4504 or Mr. Atipong Atipongsakul, Registration No. 3500 or Mr
the Directors stated in number (3) 3 7. To propose to the Annual General Meeting of Shareholders for consideration and approval of the appointment of Mr. Vichai Ruchitanont, Registration No. 4504 or Mr
Exchange Act B.E. 2535 (1992) as amended by the Securities and Exchange Act (No. 4) B.E. 2551 (2008) in conjunction with Clause 2 of Ministerial Regulation concerning Granting Approval for Undertaking of